Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Nature Communications|January 11, 2017
Starved epithelial cells uptake extracellular matrix for survivalTaru Muranen, Marcin P Iwanicki, Natasha L Curry, et al.
The Journal of Biological Chemistry|July 9, 2023
Simultaneous isolation of hormone receptor-positive breast cancer organoids and fibroblasts reveals stroma-mediated resistance mechanismsJenny M Hogstrom, Kayla A Cruz, Laura M Selfors, et al.
Cell Reports|January 19, 2022
Lineage-specific silencing of PSAT1 induces serine auxotrophy and sensitivity to dietary serine starvation in luminal breast tumorsBo-Hyun Choi, Vipin Rawat, Jenny Högström, et al.
Nature Communications|October 2, 2025
Dual membrane receptor degradation via folate receptor targeting chimeraZhen Wang, Zhixin Li, Jenny Högström, et al.
Cancers|May 14, 2025
Suppression of Ovarian Cancer Cell Proliferation Is Associated with Upregulation of Cell-Matrix Adhesion Programs and Integrin-β4-Induced Cell Protection from CisplatinSadaf Farsinejad, Daniel Centeno, Jan Savas-Carstens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2023
Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical OutcomesSanna Pikkusaari, Manuela Tumiati, Anni Virtanen, et al.
Biorxiv : the Preprint Server for Biology|September 11, 2023
Differences in syncytia formation by SARS-CoV-2 variants modify host chromatin accessibility and cellular senescence via TP53Jonathan D Lee, Bridget L Menasche, Maria Mavrikaki, et al.
Cell Reports|November 22, 2023
Differences in syncytia formation by SARS-CoV-2 variants modify host chromatin accessibility and cellular senescence via TP53Jonathan D Lee, Bridget L Menasche, Maria Mavrikaki, et al.
Science Translational Medicine|August 2, 2013
mTORC1 inhibition is required for sensitivity to PI3K p110α inhibitors in PIK3CA-mutant breast cancerMoshe Elkabets, Sadhna Vora, Dejan Juric, et al.
Cancer Research|July 18, 2024
Targeting Cholesterol Biosynthesis with Statins Synergizes with AKT Inhibitors in Triple-Negative Breast CancerAlissandra L Hillis, Timothy D Martin, Haley E Manchester, et al.
Pageof 4